Latest News in the pharma Industry
Market News
Crown Bioscience and JSR Corporation to merge
21 Dec 2017
Merger integrates Crown Bioscience’s leading translational technology platform providing drug target validation, efficacy testing and patient response characterization with JSR’s IVD solutions, GMP manufacturing capabilities and worldwide distribution ...
Read more
Biogen and Ionis collaborate to identify novel therapies for the treatment of SMA
21 Dec 2017
New collaboration agreement to identify new antisense oligonucleotide drug candidates.
Read more
FDA clears myPKFiT for ADVATE to help personalize care for hemophilia A
19 Dec 2017
First and only FDA-cleared PK dosing software to support healthcare professionals in creating personalized dosing regimens for patients 16 and older with hemophilia A.
Read more
Major changes for bio supply forecast in 2018 by bioLIVE
19 Dec 2017
Integration of supply chain a critical issue as industry globalises, with a resurgence in European manufacturing and biotech markets forecast.
Read more
Hikma signs licensing agreement with Celltrion for third biosimilar product in MENA region
19 Dec 2017
Truxima is mAb biosimilar to Roche's MabThera (rituximab).
Read more
Teva to axe 25% of its total workforce
18 Dec 2017
Total cost base to be reduced by $3 billion by the end of 2019.
Read more
Femarelle launches new women’s supplement line in US
18 Dec 2017
Targeted formulas support symptoms before, during and after menopause.
Read more
Lilly and Rimidi to make diabetes management easier
15 Dec 2017
Companies will strive to make diabetes management easier through effective use of connected devices and a diabetes management software platform.
Read more
Major breakthrough for new haemophilia A treatment
15 Dec 2017
Drug trials provide mind-blowing results.
Read more
New formulation of Oncaspar receives Marketing Authorization in Europe for patients with ALL
14 Dec 2017
Freeze-dried, or lyophilized, formulation aims to improve supply management by providing the same dosing regimen as liquid Oncaspar but with a three-times longer shelf life of up to 24 months.
Read more
CMC Biologics and Harpoon Therapeutics collaborate on exciting new TriTAC molecules
14 Dec 2017
First clinical candidate, HPN424, is in development for the treatment of metastatic prostate cancer and expected to enter Phase I clinical trials in 2018.
Read more
SGS introduces GMP DNA sequencing service at its Glasgow, UK, laboratory
13 Dec 2017
Service complements existing services for this testing, to provide comprehensive analysis and characterization solutions for clients involved in the production and manufacturing of biopharmaceutical products.
Read more